Details of the Drug

General Information of Drug (ID: DMWD8MQ)

• Drug Name: DRA-161
• Synonyms: DRA-162; DRA-162); DRACO anti-CD3 therapeutic; DRA-187b based SMIP, Emergent; DRA-187b based SMIP, Trubion Pharmaceuticals; DRA-187a-based SMIP (LADA, solid organ transplantation), Emergent; DRA-187a-based SMIP (LADA, solid organ transplantation), Trubion Pharmaceuticals

Indication

Disease Entry	ICD 11	Status	REF
Diabetic complication	5A2Y	Investigative	[1]

• Cross-matching ID: TTD ID: D0K6CG

References

• [1] The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.